Mar 01, 2019 EBMT receives a regulatory qualification from the European Medicine Agency (EMA) on the use of its patient registry to support novel CAR T-cell therapies.
Feb 15, 2019 Position statement providing general information for patients and carers considering HSCT for severe autoimmune diseases
Dec 15, 2018 Joint Educational Meeting of the Autoimmune Diseases and Aplastic Anaemia Working Parties
